BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
5 Instructive Toy Brands for Youngsters - 2Can a mammogram help identify heart disease?
- 3Moderna to complete US mRNA manufacturing network with $140 million investment
- 4Exploring the Market: Unsold Rams May Be Less expensive Than You Naturally suspect
- 5Thousands of Walgreens nasal spray bottles recalled. See which ones.
- Rocket shines under the northern lights | Space photo of the day for March 25, 2026
- What you need to know about Trump accounts as Michael and Susan Dell donate $6 billion to the new early childhood investment program
- I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.
- Must-See Attractions in Washington, D.C.
- They died 'doing what they loved': The stories of workers in their 80s who died on the job
- Famous Restroom Beautifying Styles For 2024
- West Bank man indicted for extortion, impersonation of IAF pilot, Mossad agent, illegal entry
- The Advancement and Effect of Dental Embed Innovation on Oral Wellbeing
- ‘Integral part of our nation’: Herzog visits Franciscan Sisters in Jerusalem ahead of Christmas
